
Appropriate Prescribing of Sedating Medications to Seniors
Aging & Supportive Care
2024-09-30 – Present
CWC has identified de-prescribing of antipsychotic and sedative medications in seniors over the age of 65 years as a priority area for improvement. Antipsychotics and sedatives (e.g. benzodiazepines and z-drugs, like zopiclone) are commonly prescribed to seniors with dementia and other cognitive impairments to manage aggressive behaviours or insomnia. However, these medications have side effects that can reduce quality of life and introduce additional unwanted behavior risks. Many of these drugs are also identified in the Beers Criteria® as having potentially adverse effects in older people, with sufficient clinical evidence to avoid prescribing when there is no indication for use.
Associate Dean, PLP, Dr. Kelly Burak and PLP Medical Director Dr. Douglas Woodhouse are leading three related PLP projects aimed at improving prescribing of sedating medications (antipsychotics, antidepressants, sedatives) to seniors 65+ in Alberta, with a focus on patients residing in Long Term Care (LTC or Type A) and Designated Supported Living (DSL or Type B) sites. An Advisory Panel, with subject matter expertise in these areas, has been established to advise on these projects with Drs. Patrick Quail, Vivian Ewa, Zahra Goodarzi, Cassandra Hoggard, Jed Shimizu, and Marjan Abbasi.
These three projects are as follows
Reducing Overprescribing of Sedating Medications to Seniors in Alberta (CWA): Addressing Health Inequities
Appropriate Prescribing of Sedating Medications to Seniors in the Calgary Zone
Reducing Overprescribing of Sedating Medications to Seniors in Alberta (CWA): Provincial Spread and Scale